Notrox Research Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 5.00 M
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -4.10%
- Profit Growth -14.71%
- Ebitda -2.98%
- Net Worth 28.65%
- Total Assets 43.45%
About Notrox Research
Notrox Research Private Limited (NRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 May 2014 and has a history of Ten years and nine months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hanumanthappa Kumar and Bangalore Shanthala serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2014PTC074596
- Company No.
074596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
What products or services does Notrox Research Private Limited offer?
Notrox Research Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Clinical Research Services.
Who are the key members and board of directors at Notrox Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanumanthappa Kumar  | Director | 23-May-2014 | Current |
| Bangalore Shanthala | Director | 23-May-2014 | Current |
Financial Performance of Notrox Research.
Notrox Research Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 4.1% decrease. The company also saw a substantial fall in profitability, with a 14.71% decrease in profit. The company's net worth Soared by an impressive increase of 28.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Notrox Research?
In 2021, Notrox Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Notrox Research?
Notrox Research has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Notrox Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Notrox Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.